跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Cetirigen Plus - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Cetirigen Plus
Approved
STANDARD
Cetirigen Plus
Azarias Pharmaceutical Laboratories Inc.,
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
f7c74e84a4affaa4
Company
Azarias Pharmaceutical Laboratories Inc.,
Type
Standard
Approval Details
Approval Id
f7c74e84a4affaa4
Drug Approval Philippines Name
Cetirigen Plus
Product Name
Cetirigen Plus
Registration Number
DRP-9266
Brand Name
Cetirigen Plus
Generic Name
Cetirizine (as Dihydrochloride) + Phenylephrine Hydrochloride
Dosage Form
Tablet
Dosage Strength
5mg/10mg
Manufacturer
Azarias Pharmaceutical Laboratories Inc.,
Trader
Eba Generisch Trading Inc.
Issuance Date
25 November 2020
Expiry Date
25 November 2025
Classification
Over-the-Counter (OTC)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
f7c74e84a4affaa4
Type
Standard
Back to Philippines FDA Approvals